sarcopenia; quality of life; questionnaire; older people
Abstract :
[en] BACKGROUND:
the impact of sarcopenia on quality of life is currently assessed by generic tools. However, these tools may not detect subtle effects of this specific condition on quality of life.
OBJECTIVE:
the aim of this study was to develop a sarcopenia-specific quality of life questionnaire (SarQoL, Sarcopenia Quality of Life) designed for community-dwelling elderly subjects aged 65 years and older.
SETTINGS:
participants were recruited in an outpatient clinic in Liège, Belgium.
SUBJECTS:
sarcopenic subjects aged 65 years or older.
METHODS:
the study was articulated in the following four stages: (i) Item generation-based on literature review, sarcopenic subjects' opinion, experts' opinion, focus groups; (ii) Item reduction-based on sarcopenic subjects' and experts' preferences; (iii) Questionnaire generation-developed during an expert meeting; (iv) Pretest of the questionnaire-based on sarcopenic subjects' opinion.
RESULTS:
the final version of the questionnaire consists of 55 items translated into 22 questions rated on a 4-point Likert scale. These items are organised into seven domains of dysfunction: Physical and mental health, Locomotion, Body composition, Functionality, Activities of daily living, Leisure activities and Fears. In view of the pretest, the SarQoL is easy to complete, independently, in ∼10 min.
CONCLUSIONS:
the first version of the SarQoL, a specific quality of life questionnaire for sarcopenic subjects, has been developed and has been shown to be comprehensible by the target population. Investigations are now required to test the psychometric properties (internal consistency, test-retest reliability, divergent and convergent validity, discriminant validity, floor and ceiling effects) of this questionnaire.
Disciplines :
General & internal medicine
Author, co-author :
Beaudart, Charlotte ; Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Biver, Emmanuel
Reginster, Jean-Yves ; Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Rizzoli, René
Rolland, Yves
Bautmans, Ivan
PETERMANS, Jean ; Centre Hospitalier Universitaire de Liège - CHU > Gériatrie
GILLAIN, Sophie ; Centre Hospitalier Universitaire de Liège - CHU > Gériatrie
Buckinx, Fanny ; Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
van beveren, Julien; Université de Liège - ULiège
Jacqemain, Marc; Université de Liège - ULiège
Italiano, Patrick ; Université de Liège > Faculté des sciences sociales > Sociologie des identités contemporaines
Dardenne, Nadia ; Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Bruyère, Olivier ; Université de Liège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé
Cooper C, Dere W, Evans Wet al. Frailty and sarcopenia: definitions and outcome parameters. Osteoporos Int 2012; 23: 1839-48.
Baumgartner RN, Koehler KM, Gallagher D et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-63.
Beaudart C, Rizzoli R, Bruyere O et al. Sarcopenia: burden and challenges for Public Health. 2014. Arch Public Health 2014; 72: 45.
Lauretani F, Russo CR, Bandinelli S et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 2003; 95: 1851-60.
Janssen I. Influence of sarcopenia on the development of physical disability: the Cardiovascular Health Study. J Am Geriatr Soc 2006; 54: 56-62.
Visser M, Goodpaster BH, Kritchevsky SB et al. Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons. J Gerontol A Biol Sci Med Sci 2005; 60: 324-33.
Lang T, Streeper T, Cawthon P et al. Sarcopenia: etiology, clinical consequences, intervention, and assessment. Osteoporos Int 2010; 21: 543-59.
Rizzoli R, Reginster JY, Arnal JF et al. Quality of life in sarcopenia and frailty. Calcif Tissue Int 2013; 93: 101-20.
Sayer AA, Dennison EM, Syddall HE et al. Type 2 diabetes, muscle strength, and impaired physical function: the tip of the iceberg? Diabetes Care 2005; 28: 2541-2.
Sayer AA, Syddall HE, Martin HJ et al. Is grip strength associated with health-related quality of life? Findings from the Hertfordshire Cohort Study. Age Ageing 2006; 35: 409-15.
Kull M, Kallikorm R, Lember M. Impact of a new sarco-osteopenia definition on health-related quality of life in a population-based cohort in Northern Europe. J Clin Densitom 2012; 15: 32-8.
Patel HP, Syddall HE, Jameson K et al. Prevalence of sarcopenia in community-dwelling older people in the UK using the European Working Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS). Age Ageing 2013. doi:10.1093/ageing/afs197.
US Department of Health and Human Services Food and Drug Administration Guidance for Industry. Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Health Qual Life Outcomes 2006; 4: 79.
Johnson C, Aaronson NK, Blazeby JM et al. EORTS quality of life group: guidelines for developing questionnaire modules. Eur Organ Res Treat Cancer 2011. http://groups.eortc.be/qol/sites/default/files/archives/guidelines_for_developing_questionnaire-_final.pdf.
Guyatt GH, Bombardier C, Tugwell PX. Measuring diseasespecific quality of life in clinical trials. CMAJ 1986; 134: 889-95.
Husson O, Haak HR, Mols F et al. Development of a diseasespecific health-related quality of life questionnaire (THYCAQoL) for thyroid cancer survivors. Acta Oncol 2013; 52: 447-54.
DunnGalvin A, de BlokFlokstra BM, Burks AW et al. Food allergy QoL questionnaire for children aged 0-12 years: content, construct, and cross-cultural validity. Clin Exp Allergy 2008; 38: 977-86.
Storck AJ, Laupland KB, Read RR et al. Development of a Health-Related Quality of Life Questionnaire (HRQL) for patients with Extremity Soft Tissue Infections (ESTI). BMC Infect Dis 2006; 6: 148.
Mohtadi NG, Griffin DR, Pedersen ME et al. The development and validation of a self-administered quality-of-life outcome measure for young, active patients with symptomatic hip disease: the International Hip Outcome Tool (iHOT-33). Arthroscopy 2012; 28: 595-605; quiz 606-10 e1.
Cronin L, Guyatt G, Griffith L et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 1998; 83: 1976-87.
Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European Consensus on Definition and Diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-23.
Beaudart C, Reginster JY, Petermans J et al. Quality of life and physical components linked to sarcopenia: The SarcoPhAge study. Exp Gerontol. 2015; 69: 103-10.
Krippendorf KL. Content Analysis: An Introduction to Its Methodology. Beverly Hills, CA: Sage, 1980.
Go SW, Cha YH, Lee JA et al. Association between sarcopenia, bone density, and health-related quality of life in Korean men. Korean J Fam Med 2013; 34: 281-8.
Silva Neto LS, Karnikowiski MG, Tavares AB et al. Association between sarcopenia, sarcopenic obesity, muscle strength and quality of life variables in elderly women. Rev Bras Fisioter 2012; 16: 360-7.
Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci 2002; 57: M772-7.
Syddall HE, Martin HJ, Harwood RH et al. The SF-36: a simple, effective measure of mobility-disability for epidemiological studies. J Nutr Heal Aging 2009; 13: 57-62.
Ware JE Jr. The SF-36 health survey. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edition. Philadalphia: Lippincott-Raven, 1996; 337-44.
Wilburn J, McKenna SP, Twiss J et al. Assessing quality of life in Crohn's disease: development and validation of the Crohn's Life Impact Questionnaire (CLIQ). Qual Life Res 2015. doi:10.1007/s11136-015-0947-1.
Goh SGK, Rusli BN, Khalid BAK. Development and validation of the Asian Diabetes Quality of Life (AsianDQOL) Questionnaire. Diabetes Res Clin Pract 2015. doi:10.1016/j.diabres.2015.02.009.
